Detalhe da pesquisa
1.
Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals.
PLoS Pathog
; 19(7): e1011546, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523415